Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Spine Biologics Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Global Spine Biologics Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Industry: Medical Devices & Consumables
Published Date: 2026-07-11
Pages: 137 Pages
Report ld: 5558847
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Spine Biologics Market Size(US$)
CAGR 2026-2032
6.3%
Market Size,2032
USD 3,864
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 2,672 million
Market Forecast in 2032(Value)
US$ 3,864 million
CAGR
6.3%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Spine Biologics market size was US$ 2595 million in 2025 and is forecast to reach a readjusted size of US$ 3864 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Spine Biologics are implantable biological materials and regenerative products used in spinal fusion, bone-defect repair and spinal reconstruction to stimulate new bone formation, improve the local healing environment and increase the probability of successful fusion. Major categories include allograft bone, demineralized bone matrix, cellular bone matrices, synthetic bone-graft substitutes, recombinant bone morphogenetic proteins and collagen-based carrier systems. Depending on their composition, these products may provide an osteoconductive scaffold, osteoinductive biological signals or cells with osteogenic potential. They are generally used together with interbody cages, screws and fixation systems in cervical, thoracic and lumbar procedures for degenerative disease, deformity, trauma, tumor reconstruction and revision surgery. Their principal value is to reduce the additional morbidity associated with harvesting autologous bone while improving fusion predictability in complex or high-risk patients. In 2025, global Spine Biologics production reached approximately 1240 k units.The average gross profit margin of this product is 75%.
Population aging, the increasing burden of degenerative spinal disorders and the growing complexity and personalization of fusion procedures are supporting long-term demand for spine biologics. Compared with reliance on autograft alone, commercial biologic products can reduce donor-site pain and complications while providing additional support for patients with osteoporosis, multilevel fusion, spinal deformity or revision surgery. As navigation, robotics, minimally invasive approaches and advanced interbody devices become more widely adopted, biologics are evolving from supplementary graft materials into critical components influencing fusion quality, procedural efficiency and overall treatment value. The continued expansion of allograft, cellular matrix, synthetic graft and growth-factor portfolios by major spine companies further demonstrates their growing role within integrated spinal-care solutions.
The principal market constraints are clinical-evidence requirements, regulatory complexity and product-safety concerns. Materials differ in osteogenic performance, resorption profile, handling characteristics and patient suitability, making purchasing decisions increasingly dependent on long-term fusion evidence and real-world outcomes. Allograft and cellular products also require rigorous donor screening, infection control, tissue traceability and manufacturing consistency. Regulatory authorities impose strict requirements covering processing, storage and adverse-event management, while historical tissue-transmission events have increased hospital scrutiny of supply-chain safety. Recombinant growth-factor products must be used according to approved indications, dosages and application methods, as concerns regarding off-label use, local inflammatory responses and unwanted bone formation can influence clinical adoption and reimbursement.
Hospital and surgeon purchasing is shifting from selecting a general bone-filling material toward matching the biologic strategy to each patient’s fusion risk. Younger patients undergoing single-level procedures may prioritize affordability and ease of use, while elderly patients, those with poor bone quality and patients requiring multilevel or revision surgery place greater emphasis on biological performance and fusion certainty. Product formats are moving toward injectable, moldable and low-migration designs that can pass through minimally invasive access channels and integrate more closely with interbody-device architecture, surgical approach and digital preoperative planning. Products supported by comprehensive clinical evidence, consistent handling and multiple delivery formats are more likely to enter standardized hospital pathways and generate durable surgeon loyalty and recurring demand.
The global Spine Biologics market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
By Company
- Medtronic
- Stryker
- Johnson & Johnson
- Zimmer Biomet
- Orthofix
- Globus Medical
- SeaSpine
- Bioventus
- Xtant Medical
- Kuros Biosciences
- Beijing Chunlizhengda
- Bonovo Orthopedics
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Bone Graft
- Bone Graft Substitute
- Platelet Rich Plasma (PRP)
- BMAC (Bone Marrow Aspirate Concentrate)
Segment by Application
- Spinal Fusion
- Bone Regeneration
- Orthopedic Reconstruction
- Minimally Invasive Spine Surgery
- Other
Segment by Category
- Lumbar Fusion
- Cervical Fusion
- Deformity Correction
- Revision Spine Surgery
- Other
Segment by Division
- Putty
- Strip
- Granule
- Sponge/Collagen Carrier
- Other
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Spine Biologics sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Spine Biologics manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Spine Biologics product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Spine Biologics value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Spine Biologics Product Scope
1.2 Spine Biologics by Type
1.2.1 Global Spine Biologics Sales by Type (2021, 2025 & 2032)
1.2.2 Bone Graft
1.2.3 Bone Graft Substitute
1.2.4 Platelet Rich Plasma (PRP)
1.2.5 BMAC (Bone Marrow Aspirate Concentrate)
1.3 Spine Biologics by Application
1.3.1 Global Spine Biologics Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Spinal Fusion
1.3.3 Bone Regeneration
1.3.4 Orthopedic Reconstruction
1.3.5 Minimally Invasive Spine Surgery
1.3.6 Other
1.4 Global Spine Biologics Market Estimates and Forecasts (2021-2032)
1.4.1 Global Spine Biologics Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Spine Biologics Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Spine Biologics Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Spine Biologics Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Spine Biologics Historical Market Scenario by Region (2021-2026)
2.2.1 Global Spine Biologics Sales Market Share by Region (2021-2026)
2.2.2 Global Spine Biologics Revenue Market Share by Region (2021-2026)
2.3 Global Spine Biologics Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Spine Biologics Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Spine Biologics Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Spine Biologics Market Size and Prospects (2021-2032)
2.4.2 Europe Spine Biologics Market Size and Prospects (2021-2032)
2.4.3 China Spine Biologics Market Size and Prospects (2021-2032)
2.4.4 Japan Spine Biologics Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Spine Biologics Historical Market Review by Type (2021-2026)
3.1.1 Global Spine Biologics Sales by Type (2021-2026)
3.1.2 Global Spine Biologics Revenue by Type (2021-2026)
3.1.3 Global Spine Biologics Average Price by Type (2021-2026)
3.2 Global Spine Biologics Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Spine Biologics Sales Forecast by Type (2027-2032)
3.2.2 Global Spine Biologics Revenue Forecast by Type (2027-2032)
3.2.3 Global Spine Biologics Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Spine Biologics
4 Global Market Size by Application
4.1 Global Spine Biologics Historical Market Review by Application (2021-2026)
4.1.1 Global Spine Biologics Sales by Application (2021-2026)
4.1.2 Global Spine Biologics Revenue by Application (2021-2026)
4.1.3 Global Spine Biologics Average Price by Application (2021-2026)
4.2 Global Spine Biologics Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Spine Biologics Sales Forecast by Application (2027-2032)
4.2.2 Global Spine Biologics Revenue Forecast by Application (2027-2032)
4.2.3 Global Spine Biologics Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Spine Biologics Applications
5 Competition Landscape by Players
5.1 Global Spine Biologics Sales by Player (2021-2026)
5.2 Global Top Spine Biologics Players by Revenue (2021-2026)
5.3 Global Spine Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Spine Biologics revenue as of 2025
5.4 Global Spine Biologics Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Spine Biologics, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Spine Biologics, Product Type & Application
5.7 Global Key Manufacturers of Spine Biologics, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Spine Biologics Sales by Company
6.1.1.1 North America Spine Biologics Sales by Company (2021-2026)
6.1.1.2 North America Spine Biologics Revenue by Company (2021-2026)
6.1.2 North America Spine Biologics Sales Breakdown by Type (2021-2026)
6.1.3 North America Spine Biologics Sales Breakdown by Application (2021-2026)
6.1.4 North America Spine Biologics Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Spine Biologics Sales by Company
6.2.1.1 Europe Spine Biologics Sales by Company (2021-2026)
6.2.1.2 Europe Spine Biologics Revenue by Company (2021-2026)
6.2.2 Europe Spine Biologics Sales Breakdown by Type (2021-2026)
6.2.3 Europe Spine Biologics Sales Breakdown by Application (2021-2026)
6.2.4 Europe Spine Biologics Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Spine Biologics Sales by Company
6.3.1.1 China Spine Biologics Sales by Company (2021-2026)
6.3.1.2 China Spine Biologics Revenue by Company (2021-2026)
6.3.2 China Spine Biologics Sales Breakdown by Type (2021-2026)
6.3.3 China Spine Biologics Sales Breakdown by Application (2021-2026)
6.3.4 China Spine Biologics Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Spine Biologics Sales by Company
6.4.1.1 Japan Spine Biologics Sales by Company (2021-2026)
6.4.1.2 Japan Spine Biologics Revenue by Company (2021-2026)
6.4.2 Japan Spine Biologics Sales Breakdown by Type (2021-2026)
6.4.3 Japan Spine Biologics Sales Breakdown by Application (2021-2026)
6.4.4 Japan Spine Biologics Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Medtronic
7.1.1 Medtronic Company Information
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Medtronic Spine Biologics Products Offered
7.1.5 Medtronic Recent Development
7.2 Stryker
7.2.1 Stryker Company Information
7.2.2 Stryker Business Overview
7.2.3 Stryker Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Stryker Spine Biologics Products Offered
7.2.5 Stryker Recent Development
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Information
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Johnson & Johnson Spine Biologics Products Offered
7.3.5 Johnson & Johnson Recent Development
7.4 Zimmer Biomet
7.4.1 Zimmer Biomet Company Information
7.4.2 Zimmer Biomet Business Overview
7.4.3 Zimmer Biomet Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Zimmer Biomet Spine Biologics Products Offered
7.4.5 Zimmer Biomet Recent Development
7.5 Orthofix
7.5.1 Orthofix Company Information
7.5.2 Orthofix Business Overview
7.5.3 Orthofix Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Orthofix Spine Biologics Products Offered
7.5.5 Orthofix Recent Development
7.6 Globus Medical
7.6.1 Globus Medical Company Information
7.6.2 Globus Medical Business Overview
7.6.3 Globus Medical Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Globus Medical Spine Biologics Products Offered
7.6.5 Globus Medical Recent Development
7.7 SeaSpine
7.7.1 SeaSpine Company Information
7.7.2 SeaSpine Business Overview
7.7.3 SeaSpine Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
7.7.4 SeaSpine Spine Biologics Products Offered
7.7.5 SeaSpine Recent Development
7.8 Bioventus
7.8.1 Bioventus Company Information
7.8.2 Bioventus Business Overview
7.8.3 Bioventus Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Bioventus Spine Biologics Products Offered
7.8.5 Bioventus Recent Development
7.9 Xtant Medical
7.9.1 Xtant Medical Company Information
7.9.2 Xtant Medical Business Overview
7.9.3 Xtant Medical Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Xtant Medical Spine Biologics Products Offered
7.9.5 Xtant Medical Recent Development
7.10 Kuros Biosciences
7.10.1 Kuros Biosciences Company Information
7.10.2 Kuros Biosciences Business Overview
7.10.3 Kuros Biosciences Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
7.10.4 Kuros Biosciences Spine Biologics Products Offered
7.10.5 Kuros Biosciences Recent Development
7.11 Beijing Chunlizhengda
7.11.1 Beijing Chunlizhengda Company Information
7.11.2 Beijing Chunlizhengda Business Overview
7.11.3 Beijing Chunlizhengda Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
7.11.4 Beijing Chunlizhengda Spine Biologics Products Offered
7.11.5 Beijing Chunlizhengda Recent Development
7.12 Bonovo Orthopedics
7.12.1 Bonovo Orthopedics Company Information
7.12.2 Bonovo Orthopedics Business Overview
7.12.3 Bonovo Orthopedics Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
7.12.4 Bonovo Orthopedics Spine Biologics Products Offered
7.12.5 Bonovo Orthopedics Recent Development
8 Spine Biologics Manufacturing Cost Analysis
8.1 Spine Biologics Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Spine Biologics
8.4 Spine Biologics Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Spine Biologics Distributors List
9.3 Spine Biologics Customers
10 Spine Biologics Market Dynamics
10.1 Spine Biologics Industry Trends
10.2 Spine Biologics Market Drivers
10.3 Spine Biologics Market Challenges
10.4 Spine Biologics Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Spine Biologics Sales (US$ Million) Growth Rate by Type (2021, 2025 & 2032)
Table 2. Global Spine Biologics Sales (US$ Million) Comparison by Application (2021, 2025 & 2032)
Table 3. Global Market Spine Biologics Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Table 4. Global Spine Biologics Sales (K Units) by Region (2021-2026)
Table 5. Global Spine Biologics Sales Market Share by Region (2021-2026)
Table 6. Global Spine Biologics Revenue (US$ Million) Market Share by Region (2021-2026)
Table 7. Global Spine Biologics Revenue Share by Region (2021-2026)
Table 8. Global Spine Biologics Sales (K Units) Forecast by Region (2027-2032)
Table 9. Global Spine Biologics Sales Market Share Forecast by Region (2027-2032)
Table 10. Global Spine Biologics Revenue (US$ Million) Forecast by Region (2027-2032)
Table 11. Global Spine Biologics Revenue Share Forecast by Region (2027-2032)
Table 12. Global Spine Biologics Sales by Type (K Units) & (2021-2026)
Table 13. Global Spine Biologics Sales Share by Type (2021-2026)
Table 14. Global Spine Biologics Revenue by Type (US$ Million) & (2021-2026)
Table 15. Global Spine Biologics Average Price by Type (USD/Unit) & (2021-2026)
Table 16. Global Spine Biologics Sales by Type (K Units) & (2027-2032)
Table 17. Global Spine Biologics Revenue by Type (US$ Million) & (2027-2032)
Table 18. Global Spine Biologics Average Price by Type (USD/Unit) & (2027-2032)
Table 19. Representative Players of Each Type
Table 20. Global Spine Biologics Sales by Application (K Units) & (2021-2026)
Table 21. Global Spine Biologics Sales Share by Application (2021-2026)
Table 22. Global Spine Biologics Revenue by Application (US$ Million) & (2021-2026)
Table 23. Global Spine Biologics Average Price by Application (USD/Unit) & (2021-2026)
Table 24. Global Spine Biologics Sales by Application (K Units) & (2027-2032)
Table 25. Global Spine Biologics Revenue Market Share by Application (US$ Million) & (2027-2032)
Table 26. Global Spine Biologics Average Price by Application (USD/Unit) & (2027-2032)
Table 27. New Sources of Growth in Spine Biologics Applications
Table 28. Global Spine Biologics Sales by Company (K Units) & (2021-2026)
Table 29. Global Spine Biologics Sales Share by Company (2021-2026)
Table 30. Global Spine Biologics Revenue by Company (US$ Million) & (2021-2026)
Table 31. Global Spine Biologics Revenue Share by Company (2021-2026)
Table 32. Global Spine Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spine Biologics as of 2025)
Table 33. Global Market Spine Biologics Average Price by Company (USD/Unit) & (2021-2026)
Table 34. Global Key Manufacturers of Spine Biologics, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Spine Biologics, Product Type & Application
Table 36. Global Key Manufacturers of Spine Biologics, Date of Entry into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Spine Biologics Sales by Company (2021-2026) & (K Units)
Table 39. North America Spine Biologics Sales Market Share by Company (2021-2026)
Table 40. North America Spine Biologics Revenue by Company (2021-2026) & (US$ Million)
Table 41. North America Spine Biologics Revenue Market Share by Company (2021-2026)
Table 42. North America Spine Biologics Sales by Type (2021-2026) & (K Units)
Table 43. North America Spine Biologics Sales Market Share by Type (2021-2026)
Table 44. North America Spine Biologics Sales by Application (2021-2026) & (K Units)
Table 45. North America Spine Biologics Sales Market Share by Application (2021-2026)
Table 46. Europe Spine Biologics Sales by Company (2021-2026) & (K Units)
Table 47. Europe Spine Biologics Sales Market Share by Company (2021-2026)
Table 48. Europe Spine Biologics Revenue by Company (2021-2026) & (US$ Million)
Table 49. Europe Spine Biologics Revenue Market Share by Company (2021-2026)
Table 50. Europe Spine Biologics Sales by Type (2021-2026) & (K Units)
Table 51. Europe Spine Biologics Sales Market Share by Type (2021-2026)
Table 52. Europe Spine Biologics Sales by Application (2021-2026) & (K Units)
Table 53. Europe Spine Biologics Sales Market Share by Application (2021-2026)
Table 54. China Spine Biologics Sales by Company (2021-2026) & (K Units)
Table 55. China Spine Biologics Sales Market Share by Company (2021-2026)
Table 56. China Spine Biologics Revenue by Company (2021-2026) & (US$ Million)
Table 57. China Spine Biologics Revenue Market Share by Company (2021-2026)
Table 58. China Spine Biologics Sales by Type (2021-2026) & (K Units)
Table 59. China Spine Biologics Sales Market Share by Type (2021-2026)
Table 60. China Spine Biologics Sales by Application (2021-2026) & (K Units)
Table 61. China Spine Biologics Sales Market Share by Application (2021-2026)
Table 62. Japan Spine Biologics Sales by Company (2021-2026) & (K Units)
Table 63. Japan Spine Biologics Sales Market Share by Company (2021-2026)
Table 64. Japan Spine Biologics Revenue by Company (2021-2026) & (US$ Million)
Table 65. Japan Spine Biologics Revenue Market Share by Company (2021-2026)
Table 66. Japan Spine Biologics Sales by Type (2021-2026) & (K Units)
Table 67. Japan Spine Biologics Sales Market Share by Type (2021-2026)
Table 68. Japan Spine Biologics Sales by Application (2021-2026) & (K Units)
Table 69. Japan Spine Biologics Sales Market Share by Application (2021-2026)
Table 70. Medtronic Company Information
Table 71. Medtronic Description and Business Overview
Table 72. Medtronic Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 73. Medtronic Spine Biologics Product
Table 74. Medtronic Recent Development
Table 75. Stryker Company Information
Table 76. Stryker Description and Business Overview
Table 77. Stryker Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 78. Stryker Spine Biologics Product
Table 79. Stryker Recent Development
Table 80. Johnson & Johnson Company Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 83. Johnson & Johnson Spine Biologics Product
Table 84. Johnson & Johnson Recent Development
Table 85. Zimmer Biomet Company Information
Table 86. Zimmer Biomet Description and Business Overview
Table 87. Zimmer Biomet Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 88. Zimmer Biomet Spine Biologics Product
Table 89. Zimmer Biomet Recent Development
Table 90. Orthofix Company Information
Table 91. Orthofix Description and Business Overview
Table 92. Orthofix Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 93. Orthofix Spine Biologics Product
Table 94. Orthofix Recent Development
Table 95. Globus Medical Company Information
Table 96. Globus Medical Description and Business Overview
Table 97. Globus Medical Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 98. Globus Medical Spine Biologics Product
Table 99. Globus Medical Recent Development
Table 100. SeaSpine Company Information
Table 101. SeaSpine Description and Business Overview
Table 102. SeaSpine Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 103. SeaSpine Spine Biologics Product
Table 104. SeaSpine Recent Development
Table 105. Bioventus Company Information
Table 106. Bioventus Description and Business Overview
Table 107. Bioventus Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 108. Bioventus Spine Biologics Product
Table 109. Bioventus Recent Development
Table 110. Xtant Medical Company Information
Table 111. Xtant Medical Description and Business Overview
Table 112. Xtant Medical Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 113. Xtant Medical Spine Biologics Product
Table 114. Xtant Medical Recent Development
Table 115. Kuros Biosciences Company Information
Table 116. Kuros Biosciences Description and Business Overview
Table 117. Kuros Biosciences Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 118. Kuros Biosciences Spine Biologics Product
Table 119. Kuros Biosciences Recent Development
Table 120. Beijing Chunlizhengda Company Information
Table 121. Beijing Chunlizhengda Description and Business Overview
Table 122. Beijing Chunlizhengda Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 123. Beijing Chunlizhengda Spine Biologics Product
Table 124. Beijing Chunlizhengda Recent Development
Table 125. Bonovo Orthopedics Company Information
Table 126. Bonovo Orthopedics Description and Business Overview
Table 127. Bonovo Orthopedics Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 128. Bonovo Orthopedics Spine Biologics Product
Table 129. Bonovo Orthopedics Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Spine Biologics Distributors List
Table 133. Spine Biologics Customers List
Table 134. Spine Biologics Market Trends
Table 135. Spine Biologics Market Drivers
Table 136. Spine Biologics Market Challenges
Table 137. Spine Biologics Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Spine Biologics Product Picture
Figure 2. Global Spine Biologics Sales (US$ Million) by Type (2021, 2025 & 2032)
Figure 3. Global Spine Biologics Sales Market Share by Type in 2025 & 2032
Figure 4. Bone Graft Product Picture
Figure 5. Bone Graft Substitute Product Picture
Figure 6. Platelet Rich Plasma (PRP) Product Picture
Figure 7. BMAC (Bone Marrow Aspirate Concentrate) Product Picture
Figure 8. Global Spine Biologics Sales (US$ Million) by Application (2021, 2025 & 2032)
Figure 9. Global Spine Biologics Sales Market Share by Application in 2025 & 2032
Figure 10. Spinal Fusion Examples
Figure 11. Bone Regeneration Examples
Figure 12. Orthopedic Reconstruction Examples
Figure 13. Minimally Invasive Spine Surgery Examples
Figure 14. Other Examples
Figure 15. Global Spine Biologics Sales, (US$ Million), 2021 VS 2025 VS 2032
Figure 16. Global Spine Biologics Sales Growth Rate (2021-2032) & (US$ Million)
Figure 17. Global Spine Biologics Sales (K Units) Growth Rate (2021-2032)
Figure 18. Global Spine Biologics Price Trends Growth Rate (2021-2032) & (USD/Unit)
Figure 19. Spine Biologics Report Years Considered
Figure 20. Global Market Spine Biologics Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Figure 21. Global Spine Biologics Revenue Market Share by Region: 2021 VS 2025
Figure 22. North America Spine Biologics Revenue (US$ Million) Growth Rate (2021-2032)
Figure 23. North America Spine Biologics Sales (K Units) Growth Rate (2021-2032)
Figure 24. Europe Spine Biologics Revenue (US$ Million) Growth Rate (2021-2032)
Figure 25. Europe Spine Biologics Sales (K Units) Growth Rate (2021-2032)
Figure 26. China Spine Biologics Revenue (US$ Million) Growth Rate (2021-2032)
Figure 27. China Spine Biologics Sales (K Units) Growth Rate (2021-2032)
Figure 28. Japan Spine Biologics Revenue (US$ Million) Growth Rate (2021-2032)
Figure 29. Japan Spine Biologics Sales (K Units) Growth Rate (2021-2032)
Figure 30. Global Spine Biologics Revenue Share by Type (2021-2026)
Figure 31. Global Spine Biologics Sales Share by Type (2027-2032)
Figure 32. Global Spine Biologics Revenue Share by Type (2027-2032)
Figure 33. Global Spine Biologics Revenue Share by Application (2021-2026)
Figure 34. Global Spine Biologics Revenue Market Share by Application in 2021 & 2025
Figure 35. Global Spine Biologics Sales Share by Application (2027-2032)
Figure 36. Global Spine Biologics Revenue Share by Application (2027-2032)
Figure 37. Global Spine Biologics Sales Share by Company (2025)
Figure 38. Global Spine Biologics Revenue Share by Company (2025)
Figure 39. Global 5 Largest Spine Biologics Players Market Share by Revenue in Spine Biologics: 2021 & 2025
Figure 40. Spine Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 41. Manufacturing Cost Structure of Spine Biologics
Figure 42. Manufacturing Process Analysis of Spine Biologics
Figure 43. Spine Biologics Industrial Chain
Figure 44. Channels of Distribution (Direct Vs Distribution)
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Spine Biologics in 2032?
The global market size of Spine Biologics in 2032 was 3864 Million USD.
Which companies rank high in the global Spine Biologics market?
What is the annual compound growth rate of the global Spine Biologics market size from 2026 to 2032?
What was the global market size of Spine Biologics in 2026?
Which region is expected to have the highest market share?
Related Reports
Global Spine Biologics Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Spine Biologics market is projected to grow from US$ 2595 million in 2025 to US$ 3864 million by 2032, at a CAGR of 6.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-07-11
Pages: 169
USD 4900.00
(Single User License)
Global Spine Biologics Market Research Report 2026
The global Spine Biologics market was valued at US$ 2595 million in 2025 and is anticipated to reach US$ 3864 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-07-11
Pages: 121
USD 2900.00
(Single User License)
Spine Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Spine Biologics was estimated to be worth US$ 2595 million in 2025 and is projected to reach US$ 3864 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-07-11
Pages: 142
USD 3950.00
(Single User License)
Global Spine Biologics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Spine Biologics market is projected to grow from US$ 2520 million in 2024 to US$ 3153 million by 2031, at a CAGR of 3.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 164
USD 4900.00
(Single User License)
Global Spine Biologics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Spine Biologics was estimated to be worth US$ 2520 million and is forecast to reach approximately US$ 3153 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 152
USD 5900.00
(Single User License)
Global Spine Biologics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Spine Biologics market size was US$ 2520 million in 2024 and is forecast to a readjusted size of US$ 3153 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 97
USD 4250.00
(Single User License)
Spine Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Spine Biologics was estimated to be worth US$ 2520 million in 2024 and is forecast to a readjusted size of US$ 3153 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 121
USD 3950.00
(Single User License)
Global Spine Biologics Market Research Report 2025
The global market for Spine Biologics was valued at US$ 2520 million in the year 2024 and is projected to reach a revised size of US$ 3153 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Published Date: 2025-01-16
Pages: 91
USD 2900.00
(Single User License)
Global Spine Biologics Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Published Date: 2024-04-17
Pages: 161
USD 5600.00
(Single User License)
Global Spine Biologics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Published Date: 2024-04-16
Pages: 150
USD 5900.00
(Single User License)
Global Spine Biologics Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Spine Biologics market is projected to grow from US$ 2595 million in 2025 to US$ 3864 million by 2032, at a CAGR of 6.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-07-11
Pages: 169
USD 4900.00 (Single User License)Global Spine Biologics Market Research Report 2026
The global Spine Biologics market was valued at US$ 2595 million in 2025 and is anticipated to reach US$ 3864 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-07-11
Pages: 121
USD 2900.00 (Single User License)Spine Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Spine Biologics was estimated to be worth US$ 2595 million in 2025 and is projected to reach US$ 3864 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-07-11
Pages: 142
USD 3950.00 (Single User License)Global Spine Biologics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Spine Biologics market is projected to grow from US$ 2520 million in 2024 to US$ 3153 million by 2031, at a CAGR of 3.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 164
USD 4900.00 (Single User License)Global Spine Biologics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Spine Biologics was estimated to be worth US$ 2520 million and is forecast to reach approximately US$ 3153 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 152
USD 5900.00 (Single User License)Global Spine Biologics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Spine Biologics market size was US$ 2520 million in 2024 and is forecast to a readjusted size of US$ 3153 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 97
USD 4250.00 (Single User License)Spine Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Spine Biologics was estimated to be worth US$ 2520 million in 2024 and is forecast to a readjusted size of US$ 3153 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 121
USD 3950.00 (Single User License)Global Spine Biologics Market Research Report 2025
The global market for Spine Biologics was valued at US$ 2520 million in the year 2024 and is projected to reach a revised size of US$ 3153 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Published: 2025-01-16
Pages: 91
USD 2900.00 (Single User License)Global Spine Biologics Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Published: 2024-04-17
Pages: 161
USD 5600.00 (Single User License)Global Spine Biologics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Published: 2024-04-16
Pages: 150
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now